NCT05976191

Brief Summary

The study was designed as a randomized controlled experimental study in order to compare the fasting blood glucose values measured by puncturing the fingertips and using the intravenous route of patients diagnosed with diabetes mellitus, and to determine the effect on patient satisfaction. The blood glucose measurement via the intravenous catheter has an effect on increasing the comfort of the patient compared to the fingertip measurement. It is thought that information can be provided to increase patient satisfaction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable diabetes-mellitus

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 4, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

August 4, 2023

Status Verified

July 1, 2023

Enrollment Period

7 months

First QC Date

July 20, 2023

Last Update Submit

July 28, 2023

Conditions

Keywords

Diabetes mellitusFear of finger piercingpatient satisfactionblood glucose measurement

Outcome Measures

Primary Outcomes (1)

  • Blood Glucose Measurement Patient Satisfaction Form

    Does intravenous blood glucose measurement have a positive effect on patient satisfaction compared to fingertip blood glucose measurement?

    four months

Study Arms (2)

experimental group

EXPERIMENTAL

Patients whose blood glucose is measured intravenously and from the fingertip

Behavioral: Patients whose blood glucose is measured intravenously and from the fingertip

control group

NO INTERVENTION

Patients with fingertip blood glucose measurement

Interventions

A satisfaction survey will be conducted after these patients have previously examined their blood glucose via intravenous route, then fingertip blood glucose will be measured and a satisfaction survey will be applied.

experimental group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older
  • No advanced hearing and vision problems
  • Able to speak and understand Turkish
  • Easy to communicate
  • literate
  • Agreeing to participate in the research voluntarily
  • Patients who are hospitalized
  • Regular finger blood sugar monitoring,
  • Patients with an intravenous vascular access date within the first 24 hours
  • Patients who had been diagnosed with Type 2 Diabetes Mellitus for at least one year were.

You may not qualify if:

  • Those who are treated with sedative drugs
  • Patients using antipsychotic medication
  • Patients with continuous drug infusion through the intravenous line
  • Patients whose intravenous vascular access date has passed 24 hours
  • Patients in unconscious, confused, apathetic state

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Istanbul University-Cerrahpaşa (IUC)

Istanbul, Şişli, 34381, Turkey (Türkiye)

RECRUITING

Istanbul University-Cerrahpaşa (IUC)

Istanbul, Şişli, 34381, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Diabetes MellitusPatient Satisfaction

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single (Participant) Identity information of the patients was concealed and verbal and written consents were obtained.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Crossover Assignment This research was designed in a pretest posttest randomized controlled experimental type
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 4, 2023

Study Start

March 1, 2023

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

August 4, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations